Novavax Coronavirus Vaccine
- All
- News
- Videos
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
European Union Seals Deal With Novavax For Upto 200 Million COVID-19 Vaccines
The European Commission has approved a supply contract with U.S. firm Novavax to buy up to 200 million doses of its potential COVID-19 vaccine, the Commission said on Wednesday.
-
India Covid Latest News LIVE Updates: India Sees Fewest Covid Cases In 75 Days; 2,726 Deaths
Novavax's COVID-19 vaccine is more than 90 per cent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
-
Novavax Covid Vaccine, To Be Made By Serum Institute, Shows 90% Efficacy
Novavax's COVID-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
-
"Hope To Launch Covovax By June 2021": Serum Institute's Adar Poonawalla
Serum Institute of India, the world's biggest vaccine maker, is hopeful of launching Covovax - developed in partnership with American vaccine developer Novavax - by June, its CEO Adar Poonawalla said today. The US-based pharma firm's Covid jab was found to be 89.3 per cent effective in a UK trial.
-
India Trial Sought for Novavax Covid Vaccine: 10 Facts
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive...
-
Serum Institute To Stockpile Novavax Vaccine From April: Adar Poonawalla
The Serum Institute of India, the world's biggest vaccine maker, will start stockpiling millions of doses of the Novavax coronavirus vaccine candidate starting around April, CEO Adar Poonawalla told the Reuters Next conference on Thursday.
-
Produced 40 Million Doses Of AstraZeneca Covid Vaccine: Serum Institute
Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's rival shot, as they both seek regulatory approval.
-
Novavax Delays US Trial Of COVID-19 Vaccine Candidate To November
Novavax Inc on Tuesday delayed the start of a late-stage US trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing process.
-
US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal
US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.
-
US Awards $1.6 Billion To This Firm For COVID-19 Vaccine
The US on Tuesday announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed.
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
European Union Seals Deal With Novavax For Upto 200 Million COVID-19 Vaccines
The European Commission has approved a supply contract with U.S. firm Novavax to buy up to 200 million doses of its potential COVID-19 vaccine, the Commission said on Wednesday.
-
India Covid Latest News LIVE Updates: India Sees Fewest Covid Cases In 75 Days; 2,726 Deaths
Novavax's COVID-19 vaccine is more than 90 per cent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
-
Novavax Covid Vaccine, To Be Made By Serum Institute, Shows 90% Efficacy
Novavax's COVID-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
-
"Hope To Launch Covovax By June 2021": Serum Institute's Adar Poonawalla
Serum Institute of India, the world's biggest vaccine maker, is hopeful of launching Covovax - developed in partnership with American vaccine developer Novavax - by June, its CEO Adar Poonawalla said today. The US-based pharma firm's Covid jab was found to be 89.3 per cent effective in a UK trial.
-
India Trial Sought for Novavax Covid Vaccine: 10 Facts
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive...
-
Serum Institute To Stockpile Novavax Vaccine From April: Adar Poonawalla
The Serum Institute of India, the world's biggest vaccine maker, will start stockpiling millions of doses of the Novavax coronavirus vaccine candidate starting around April, CEO Adar Poonawalla told the Reuters Next conference on Thursday.
-
Produced 40 Million Doses Of AstraZeneca Covid Vaccine: Serum Institute
Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's rival shot, as they both seek regulatory approval.
-
Novavax Delays US Trial Of COVID-19 Vaccine Candidate To November
Novavax Inc on Tuesday delayed the start of a late-stage US trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing process.
-
US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal
US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.
-
US Awards $1.6 Billion To This Firm For COVID-19 Vaccine
The US on Tuesday announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed.
